Cost of developing drugs is increasing; now over $2.2 billion for one drug

The development of new drugs is more expensive than ever. Last year, it cost an average of over $2.23 billion to develop one new drug.

This is shown by a recent report from Deloitte, reported by MedWatch  and published on the web site of the Norwegian pharma trade group LMI

The consultancy has analyzed the development costs of the world's 20 largest pharmaceutical companies. The main reasons for the increased costs are longer and more complex research cycles, higher dropout rates in clinical trials and greater competition in popular therapeutic areas.